161 related articles for article (PubMed ID: 12038593)
1. Can we measure serum thyroglobulin?
Clark PM; Beckett G
Ann Clin Biochem; 2002 May; 39(Pt 3):196-202. PubMed ID: 12038593
[TBL] [Abstract][Full Text] [Related]
2. Thyroglobulin measurement. Techniques, clinical benefits, and pitfalls.
Spencer CA; Wang CC
Endocrinol Metab Clin North Am; 1995 Dec; 24(4):841-63. PubMed ID: 8608781
[TBL] [Abstract][Full Text] [Related]
3. Serum thyroglobulin in the monitoring of differentiated thyroid cancer.
Evans C; Tennant S; Perros P
Scand J Clin Lab Invest Suppl; 2016; 245():S119-23. PubMed ID: 27542000
[TBL] [Abstract][Full Text] [Related]
4. Comparison of thyroglobulin antibody interference in first- and second-generation thyroglobulin immunoassays.
Giovanella L; Ceriani L
Clin Chem Lab Med; 2011 Jun; 49(6):1025-7. PubMed ID: 21391869
[TBL] [Abstract][Full Text] [Related]
5. Laboratory services for thyroglobulin and implications for monitoring of differentiated thyroid cancer.
Clark PM
J Clin Pathol; 2009 May; 62(5):402-6. PubMed ID: 19398593
[TBL] [Abstract][Full Text] [Related]
6. Thyroglobulin in differentiated thyroid cancer.
Evans C; Tennant S; Perros P
Clin Chim Acta; 2015 Apr; 444():310-7. PubMed ID: 25444737
[TBL] [Abstract][Full Text] [Related]
7. Clinical review: Clinical utility of thyroglobulin antibody (TgAb) measurements for patients with differentiated thyroid cancers (DTC).
Spencer CA
J Clin Endocrinol Metab; 2011 Dec; 96(12):3615-27. PubMed ID: 21917876
[TBL] [Abstract][Full Text] [Related]
8. Antithyroglobulin antibodies in patients with differentiated thyroid carcinoma: methods of detection, interference with serum thyroglobulin measurement and clinical significance.
Rosário PW; Maia FF; Fagundes TA; Vasconcelos FP; Cardoso LD; Purisch S
Arq Bras Endocrinol Metabol; 2004 Aug; 48(4):487-92. PubMed ID: 15761511
[TBL] [Abstract][Full Text] [Related]
9. Measuring thyroglobulin and thyroglobulin autoantibody in patients with differentiated thyroid cancer.
Spencer CA; Lopresti JS
Nat Clin Pract Endocrinol Metab; 2008 Apr; 4(4):223-33. PubMed ID: 18268520
[TBL] [Abstract][Full Text] [Related]
10. Assay of thyroglobulin in serum with thyroglobulin autoantibodies: an unobtainable goal?
Mariotti S; Barbesino G; Caturegli P; Marinó M; Manetti L; Pacini F; Centoni R; Pinchera A
J Clin Endocrinol Metab; 1995 Feb; 80(2):468-72. PubMed ID: 7852506
[TBL] [Abstract][Full Text] [Related]
11. Current thyroglobulin autoantibody (TgAb) assays often fail to detect interfering TgAb that can result in the reporting of falsely low/undetectable serum Tg IMA values for patients with differentiated thyroid cancer.
Spencer C; Petrovic I; Fatemi S
J Clin Endocrinol Metab; 2011 May; 96(5):1283-91. PubMed ID: 21325460
[TBL] [Abstract][Full Text] [Related]
12. Thyroglobulin (Tg) recovery testing with quantitative Tg antibody measurement for determining interference in serum Tg assays in differentiated thyroid carcinoma.
Persoon AC; Links TP; Wilde J; Sluiter WJ; Wolffenbuttel BH; van den Ouweland JM
Clin Chem; 2006 Jun; 52(6):1196-9. PubMed ID: 16574765
[TBL] [Abstract][Full Text] [Related]
13. Thyroglobulin and thyroglobulin autoantibodies measurement using the automated KRYPTOR® platform in patients with differentiated thyroid carcinoma.
Giovanella L; Toffalori E; Ceriani L; Caputo M; Verburg FA
Horm Metab Res; 2011 Sep; 43(10):728-30. PubMed ID: 21932179
[TBL] [Abstract][Full Text] [Related]
14. Analytical and clinical performance of thyroglobulin autoantibody assays in thyroid cancer follow-up.
Katrangi W; Grebe SKG; Algeciras-Schimnich A
Clin Chem Lab Med; 2017 Oct; 55(12):1987-1994. PubMed ID: 28672730
[TBL] [Abstract][Full Text] [Related]
15. Thyroglobulin antibody (TgAb) methods - Strengths, pitfalls and clinical utility for monitoring TgAb-positive patients with differentiated thyroid cancer.
Spencer C; Fatemi S
Best Pract Res Clin Endocrinol Metab; 2013 Oct; 27(5):701-12. PubMed ID: 24094640
[TBL] [Abstract][Full Text] [Related]
16. Clinical laboratory verification of thyroglobulin concentrations in the presence of autoantibodies to thyroglobulin: comparison of EIA, radioimmunoassay and LC MS/MS measurements in an Urban Hospital.
Wheeler SE; Liu L; Blair HC; Sivak R; Longo N; Tischler J; Mulvey K; Palmer OMP
BMC Res Notes; 2017 Dec; 10(1):725. PubMed ID: 29221487
[TBL] [Abstract][Full Text] [Related]
17. A Novel Thyroglobulin Immunoassay Using the Specimen-Pretreatment Process Improves the Accuracy of Thyroglobulin Measurements in Anti-Thyroglobulin Positive Specimens.
Kitamura Y; Narita S; Kuroda Y; Yagi S; Aoyagi K
J Appl Lab Med; 2021 Nov; 6(6):1463-1475. PubMed ID: 34580727
[TBL] [Abstract][Full Text] [Related]
18. Clinical impact of thyroglobulin (Tg) and Tg autoantibody method differences on the management of patients with differentiated thyroid carcinomas.
Spencer CA; Bergoglio LM; Kazarosyan M; Fatemi S; LoPresti JS
J Clin Endocrinol Metab; 2005 Oct; 90(10):5566-75. PubMed ID: 15985472
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the BRAHMS Kryptor(®) thyroglobulin minirecovery test in patients with differentiated thyroid carcinoma.
Giovanella L; Imperiali M; Verburg FA; Ceriani L
Clin Chem Lab Med; 2013 Feb; 51(2):449-53. PubMed ID: 23095203
[TBL] [Abstract][Full Text] [Related]
20. Thyroglobulin: current status in differentiated thyroid carcinoma (review).
Harish K
Endocr Regul; 2006 Jun; 40(2):53-67. PubMed ID: 17100547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
